Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
Stock Information for Minerva Neurosciences Inc
Loading
Please wait while we load your information from QuoteMedia.